Immunovia AB IMMNOV
OMXSTO · Sweden · Health Technology
SEK 0.0850-0.01 (-8.60%)
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Immunovia AB (LTS:0G8X) reports strong commercial adoption with 27 high-risk surveillance programs using PancreaSure, while managing cash burn below guidance ahead of Medicare submission.
Immunovia AB (IMMVF) outlines its strategic initiatives and financial hurdles as it advances the PancreaSure test and seeks broader market penetration.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.